Selective inhibition of type-I geranylgeranyltransferase in vitro and in whole cells by CAAL peptidomimetics

Bioorg Med Chem. 1998 Mar;6(3):293-9. doi: 10.1016/s0968-0896(97)10040-2.

Abstract

In this paper we describe the synthesis of a family of CAAL peptidomimetics as GGTase-I inhibitors. These inhibitors lack the central dipeptide AA in the key CAAL carboxy terminal sequence of geranylgeranylated proteins and are more selective for GGTase-I over FTase. In whole cells, these compounds are very potent inhibitors of the processing of the geranylgeranylated protein Rap1A without affecting the farnesylated protein H-Ras. One derivative, GGTI-298, inhibited cell division by blocking cells in the G1 phase of the cell cycle.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3T3 Cells / drug effects
  • 3T3 Cells / enzymology
  • Alkyl and Aryl Transferases / antagonists & inhibitors*
  • Alkyl and Aryl Transferases / metabolism
  • Animals
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / pharmacology*
  • GTP-Binding Proteins / metabolism
  • Mice
  • Oligopeptides / chemical synthesis*
  • Oligopeptides / pharmacology*
  • Protein Prenylation
  • Structure-Activity Relationship
  • rap GTP-Binding Proteins

Substances

  • Enzyme Inhibitors
  • Oligopeptides
  • Alkyl and Aryl Transferases
  • geranylgeranyltransferase type-I
  • GTP-Binding Proteins
  • rap GTP-Binding Proteins